Company profile

SimBioSys, Inc.

SimBioSys, Inc. has 3 AI-enabled medical devices on the FDA list. The first decision was on December 26, 2023 and the most recent on July 8, 2025 (TumorSight Viz). Its most common review panel is Radiology (3 devices).

3AI devices
2023First decision
2025Latest decision
1Specialties

Per year

2023: 12024: 12025: 1
202320242025
SimBioSys, Inc. AI devices per year: 2023 1, 2024 1, 2025 1

By specialty

  • Radiology3

Related guides

Timeline

  1. TumorSight Viz · Radiology · QIH
  2. TumorSight Viz · Radiology · QIH
  3. TumorSight Viz · Radiology · QIH